[go: up one dir, main page]

DK0920330T3 - hCG og derivater som inhibitorer af matrixmetalloproteaser - Google Patents

hCG og derivater som inhibitorer af matrixmetalloproteaser

Info

Publication number
DK0920330T3
DK0920330T3 DK97934545T DK97934545T DK0920330T3 DK 0920330 T3 DK0920330 T3 DK 0920330T3 DK 97934545 T DK97934545 T DK 97934545T DK 97934545 T DK97934545 T DK 97934545T DK 0920330 T3 DK0920330 T3 DK 0920330T3
Authority
DK
Denmark
Prior art keywords
hcg
inhibitors
derivatives
matrix metalloproteases
metalloproteases
Prior art date
Application number
DK97934545T
Other languages
Danish (da)
English (en)
Inventor
Adriana Albini
Giorgia Orengo
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0920330T3 publication Critical patent/DK0920330T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
DK97934545T 1996-08-07 1997-07-25 hCG og derivater som inhibitorer af matrixmetalloproteaser DK0920330T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000566A IT1284876B1 (it) 1996-08-07 1996-08-07 Hcg come inibitore della collagenasi
PCT/EP1997/004053 WO1998005353A1 (fr) 1996-08-07 1997-07-25 hCG ET SES DERIVES COMME INHIBITEURS DE METALLOPROTEASES DE MATRICE

Publications (1)

Publication Number Publication Date
DK0920330T3 true DK0920330T3 (da) 2002-12-30

Family

ID=11404385

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934545T DK0920330T3 (da) 1996-08-07 1997-07-25 hCG og derivater som inhibitorer af matrixmetalloproteaser

Country Status (14)

Country Link
US (1) US6444639B2 (fr)
EP (1) EP0920330B1 (fr)
JP (1) JP3996952B2 (fr)
AR (1) AR009013A1 (fr)
AT (1) ATE228372T1 (fr)
AU (1) AU732972B2 (fr)
CA (1) CA2262582C (fr)
DE (1) DE69717463T2 (fr)
DK (1) DK0920330T3 (fr)
ES (1) ES2183205T3 (fr)
IL (1) IL128399A (fr)
IT (1) IT1284876B1 (fr)
PT (1) PT920330E (fr)
WO (1) WO1998005353A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60331367D1 (de) 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
AU2005211847B2 (en) 2004-02-13 2011-02-24 Stem Cell Therapeutics Corp. Use of luteinizing hormone (LH) and chorionic gonadotropin (hCG) for proliferation of neural stem cells and neurogenesis
KR20070073879A (ko) 2004-10-07 2007-07-10 스템 셀 테라퓨틱스 코포레이션 임신 관련 화합물의 투여를 통한 다능성 줄기 세포의증식을 자극하는 방법
US8143220B2 (en) 2006-03-17 2012-03-27 Stem Cell Therapeutics Corp. Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders
MX2017000425A (es) * 2014-07-15 2017-08-10 Zietchick Res Inst Llc Metodo para prevenir o tratar trastornos oculares.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
AU723646B2 (en) * 1995-10-16 2000-08-31 Laboratoires Serono Sa Use of human chorionic gonadotropin in the treatment of Kaposi's Sarcoma
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
AU3771197A (en) 1998-02-25
JP3996952B2 (ja) 2007-10-24
AU732972B2 (en) 2001-05-03
JP2000516582A (ja) 2000-12-12
IT1284876B1 (it) 1998-05-22
CA2262582A1 (fr) 1998-02-12
ITRM960566A1 (it) 1998-02-07
ITRM960566A0 (fr) 1996-08-07
US6444639B2 (en) 2002-09-03
AR009013A1 (es) 2000-03-08
CA2262582C (fr) 2009-02-24
PT920330E (pt) 2003-02-28
IL128399A0 (en) 2000-01-31
ATE228372T1 (de) 2002-12-15
DE69717463D1 (de) 2003-01-09
WO1998005353A1 (fr) 1998-02-12
IL128399A (en) 2006-10-05
US20010006940A1 (en) 2001-07-05
DE69717463T2 (de) 2003-07-10
EP0920330B1 (fr) 2002-11-27
EP0920330A1 (fr) 1999-06-09
ES2183205T3 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
NO991922L (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
DK0923585T3 (da) Phosphinatbaserede inhibitorer af matrixmetalloproteinaser
NO992492D0 (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
DK0938471T3 (da) Fremstillingen og anvendelsen af ortho-sulfonamido-arylhydroxamsyrer som matrix-metalloproteinase- og TACE-inhibitorer
NO20012570D0 (no) Substituerte benzimidazoler og deres anvendelse som PARP- inhibitorer
DK0944590T3 (da) Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer
NO962269D0 (no) Enzyminhibitorer
DK0922697T3 (da) Substituerede pyrazolylbenzensulfonamider og anvendelse deraf som cyclooxygenase II-inhibitorer
ATE231132T1 (de) Heterocyclische metalloprotease inhibitoren
ATE226573T1 (de) Heterozyklische metalloproteaseinhibitoren
FI972160L (fi) Matriisimetalloproteaasi-inhibiittorit
DK1047450T3 (da) Kombinationer af ACE-inhibitorer og MMP-inhibitorer
DK0934259T3 (da) Beta-sulfonamidohydroxamsyrer som matrixmetalloproteinase- og TACE-inhibitorer
NO986180D0 (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
FI961857A7 (fi) Matriksin metalloproteaasien inhibiittorit
NO996313L (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
NO995513D0 (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-A agonister
FI960482A7 (fi) Matriksin metalloproteaasien inhibiittorit
DK0888316T3 (da) 2-(3H)-oxazolonderivater og deres anvendelse som cox-2 inhibitorer
NO991316D0 (no) 3-mercaptoacetylamino-1,5-substituerte-2-okso-azepanderivater som er anvendbare som inhibitorer av matriksmetalloproteinase
DK1047665T3 (da) Matrix metalloprotease inhibitorer
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
TR199501429A2 (tr) Matriks metaloproteaz inhibitörlerinin yerine gecen 4-biarilpentanoik asitleri ve türevleri
NO954321D0 (no) 4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorer